Ipatasertib exhibits anti‑tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer <i>in vitro</i> and <i>in vivo</i>-Reference-Cited by-同舟云学术

Ipatasertib exhibits anti‑tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer in vitro and in vivo

Published:2023-07-28 Issue:3 Volume:63 Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

O'Donnell Jillian¹,Zhao Ziyi¹,Buckingham Lindsey¹,Hao Tianran¹,Suo Hongyan²,Zhang Xin²,Fan Yali²,John Catherine¹,Deng Boer¹,Shen Xiaochang¹,Sun Wenchuan¹,Secord Angeles³,Zhou Chunxiao¹,Bae‑Jump Victoria¹

Affiliation:

1. Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA

2. Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100006, P.R. China

3. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke Cancer Institute, Duke University, Durham, NC 27705, USA

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference47 articles.

1. Cancer statistics, 2023;Siegel;CA Cancer J Clin,2023

2. Endometrial cancer;Crosbie;Lancet,2022

3. Advanced and recurrent endometrial cancer: State of the art and future perspectives;Tronconi;Crit Rev Oncol Hematol,2022

4. New therapies for advanced, recurrent, and metastatic endometrial cancers;Makker;Gynecol Oncol Res Pract,2017

5. Management of stage III and IVa uterine cancer;Nero;Int J Gynecol Cancer,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic assessment of SKBR3/HER2+ breast cancer cellular response to Lapatinib and investigational Ipatasertib kinase inhibitors;Frontiers in Pharmacology;2024-08-29

2. Proteomic Assessment of SKBR3/HER2+ Breast Cancer Cellular Response to Lapatinib and Investigational Ipatasertib Kinase Inhibitors;2024-04-03

3. Engineering a three-dimensional multilayer multicellular model of endometrial cancer for high throughput drug screening and novel treatment methods;2024-02-23

4. Molecular Targeting of the Phosphoinositide-3-Protein Kinase (PI3K) Pathway across Various Cancers;International Journal of Molecular Sciences;2024-02-06

5. Effect of caspase-1 (CASP1) combined with multimodal ultrasound features on the prognosis of breast cancer patients;Translational Cancer Research;2023-08